The post ‘Mixed year for IPOs’ as crypto pulls down US IPO performance appeared on BitcoinEthereumNews.com. Investors would have been better off investing in theThe post ‘Mixed year for IPOs’ as crypto pulls down US IPO performance appeared on BitcoinEthereumNews.com. Investors would have been better off investing in the

‘Mixed year for IPOs’ as crypto pulls down US IPO performance

Investors would have been better off investing in the S&P500 than betting on US initial public offerings in 2025, with crypto and AI public debuts partly to blame.

Crypto and AI-based initial public offerings last year reportedly dragged down the performance of all US public debuts to fall behind the tech-heavy index S&P 500.

Shares of all companies that went public last year, not including closed-end funds and blank-check companies, gained 13.9% on a weighted average basis, underperforming the S&P 500’s comparative 16% gain, Bloomberg reported on Monday.

Last year saw some of the crypto industry’s biggest players go public as the Trump administration gave Wall Street the confidence to back crypto companies with billions of dollars. However, not every company performed.

Read more

Source: https://cointelegraph.com/news/mixed-year-ipos-crypto-pulls-down-2025-ipo-performance?utm_source=rss_feed&utm_medium=feed&utm_campaign=rss_partner_inbound

Market Opportunity
Talus Logo
Talus Price(US)
$0.00622
$0.00622$0.00622
+2.13%
USD
Talus (US) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.